Fidocare Xl 30 mg or 60 mg Prolonged-release tablets.
PDF Leaflet Revision Date: 22 July 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate hypertension and prophylaxis of chronic stable angina pectoris.
Dosage (summary)
Initial dose: 30 mg once daily, max: 90 mg once daily.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly patients
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Grapefruit juice
- Rifampicin
- Macrolide antibiotics
- Anti-HIV protease inhibitors
Contraindications
- Hypersensitivity to nifedipine
- Cardiogenic shock
- Aortic stenosis
- Unstable angina
- Myocardial infarction
- Hepatic impairment
Common side effects
- Headache
- Oedema
- Constipation
- Dizziness
Counselling Points
- Swallow tablets whole
- Avoid grapefruit juice
- Monitor blood pressure regularly
Serious warnings
- Risk of hypotension
- Deterioration of heart failure
- Possible obstructive symptoms
Important Disclaimer
The Fidocare Xl 30 mg or 60 mg Prolonged-release tablets. professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
